| Dr Andrew P Davis, MD | |
|
1300 116th Ave Ne, Bellevue, WA 98004 | |
| (425) 454-7912 | |
| (425) 454-7034 |
| Full Name | Dr Andrew P Davis |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 46 Years |
| Location | 1300 116th Ave Ne, Bellevue, Washington |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295741296 | NPI | - | NPPES |
| DA3097 | Other | WA | BLUE SHIELD |
| 1074087 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | MD00029453 (Washington) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Evergreenhealth Medical Center | Kirkland, WA | Hospital |
| Overlake Hospital Medical Center | Bellevue, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Eye Clinic Of Bellevue Ltd Ps | 5991694192 | 5 |
News Archive
A new research network for children and youth with special health care needs, led by researchers at the University of Colorado School of Medicine, Children's Hospital Colorado and Boston Children's Hospital, will lead, promote and coordinate national research activities to improve their systems of care.
Laugh and the world laughs with you, but wrinkle your nose and you could find yourself on your own. A new study by a scientist at the University of Portsmouth who examined the facial muscles in cadavers, has revealed that the muscles which control our facial expressions are not common to everyone.
Eye surgeons will soon have a new surgical tool to help make a complicated eye surgery less labor intensive while providing significant advantages for corneal transplant patients, as a result of an invention by a Wake Forest University Baptist Medical Center physician.
A team from the Center for Genome Engineering, within the Institute for Basic Research (IBS), succeeded in editing two genes that contribute to the fat contents of soybean oil using the new CRISPR-Cpf1 technology: an alternative of the more widely used gene editing tool CRISPR-Cas9. The results of this new plant gene editing method, applied to soybeans and wild tobacco genes, are published in Nature Communications.
Abiomed, Inc., a leading provider of breakthrough heart support technologies, today announced it has received conditional approval from the U.S. Food and Drug Administration (FDA) to begin MINI-AMI, a prospective, randomized, controlled multi-site trial to assess the potential role of the Impella 2.5 in reducing infarct size in patients with ST-elevation myocardial infarction (STEMI).
› Verified 2 days ago
| Entity Name | Edmonds Eyecare Associates Inc Ps |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558451369 PECOS PAC ID: 6103715370 Enrollment ID: O20040315000494 |
News Archive
A new research network for children and youth with special health care needs, led by researchers at the University of Colorado School of Medicine, Children's Hospital Colorado and Boston Children's Hospital, will lead, promote and coordinate national research activities to improve their systems of care.
Laugh and the world laughs with you, but wrinkle your nose and you could find yourself on your own. A new study by a scientist at the University of Portsmouth who examined the facial muscles in cadavers, has revealed that the muscles which control our facial expressions are not common to everyone.
Eye surgeons will soon have a new surgical tool to help make a complicated eye surgery less labor intensive while providing significant advantages for corneal transplant patients, as a result of an invention by a Wake Forest University Baptist Medical Center physician.
A team from the Center for Genome Engineering, within the Institute for Basic Research (IBS), succeeded in editing two genes that contribute to the fat contents of soybean oil using the new CRISPR-Cpf1 technology: an alternative of the more widely used gene editing tool CRISPR-Cas9. The results of this new plant gene editing method, applied to soybeans and wild tobacco genes, are published in Nature Communications.
Abiomed, Inc., a leading provider of breakthrough heart support technologies, today announced it has received conditional approval from the U.S. Food and Drug Administration (FDA) to begin MINI-AMI, a prospective, randomized, controlled multi-site trial to assess the potential role of the Impella 2.5 in reducing infarct size in patients with ST-elevation myocardial infarction (STEMI).
› Verified 2 days ago
| Entity Name | Eye Clinic Of Bellevue Ltd Ps |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144358417 PECOS PAC ID: 5991694192 Enrollment ID: O20040315000689 |
News Archive
A new research network for children and youth with special health care needs, led by researchers at the University of Colorado School of Medicine, Children's Hospital Colorado and Boston Children's Hospital, will lead, promote and coordinate national research activities to improve their systems of care.
Laugh and the world laughs with you, but wrinkle your nose and you could find yourself on your own. A new study by a scientist at the University of Portsmouth who examined the facial muscles in cadavers, has revealed that the muscles which control our facial expressions are not common to everyone.
Eye surgeons will soon have a new surgical tool to help make a complicated eye surgery less labor intensive while providing significant advantages for corneal transplant patients, as a result of an invention by a Wake Forest University Baptist Medical Center physician.
A team from the Center for Genome Engineering, within the Institute for Basic Research (IBS), succeeded in editing two genes that contribute to the fat contents of soybean oil using the new CRISPR-Cpf1 technology: an alternative of the more widely used gene editing tool CRISPR-Cas9. The results of this new plant gene editing method, applied to soybeans and wild tobacco genes, are published in Nature Communications.
Abiomed, Inc., a leading provider of breakthrough heart support technologies, today announced it has received conditional approval from the U.S. Food and Drug Administration (FDA) to begin MINI-AMI, a prospective, randomized, controlled multi-site trial to assess the potential role of the Impella 2.5 in reducing infarct size in patients with ST-elevation myocardial infarction (STEMI).
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Andrew P Davis, MD 1300 116th Ave Ne, Bellevue, WA 98004 Ph: (425) 454-7912 | Dr Andrew P Davis, MD 1300 116th Ave Ne, Bellevue, WA 98004 Ph: (425) 454-7912 |
News Archive
A new research network for children and youth with special health care needs, led by researchers at the University of Colorado School of Medicine, Children's Hospital Colorado and Boston Children's Hospital, will lead, promote and coordinate national research activities to improve their systems of care.
Laugh and the world laughs with you, but wrinkle your nose and you could find yourself on your own. A new study by a scientist at the University of Portsmouth who examined the facial muscles in cadavers, has revealed that the muscles which control our facial expressions are not common to everyone.
Eye surgeons will soon have a new surgical tool to help make a complicated eye surgery less labor intensive while providing significant advantages for corneal transplant patients, as a result of an invention by a Wake Forest University Baptist Medical Center physician.
A team from the Center for Genome Engineering, within the Institute for Basic Research (IBS), succeeded in editing two genes that contribute to the fat contents of soybean oil using the new CRISPR-Cpf1 technology: an alternative of the more widely used gene editing tool CRISPR-Cas9. The results of this new plant gene editing method, applied to soybeans and wild tobacco genes, are published in Nature Communications.
Abiomed, Inc., a leading provider of breakthrough heart support technologies, today announced it has received conditional approval from the U.S. Food and Drug Administration (FDA) to begin MINI-AMI, a prospective, randomized, controlled multi-site trial to assess the potential role of the Impella 2.5 in reducing infarct size in patients with ST-elevation myocardial infarction (STEMI).
› Verified 2 days ago
Kristin J Tarbet, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1810 116th Ave Ne Ste D1, Bellevue, WA 98004 Phone: 425-455-2131 Fax: 425-455-2335 | |
Dr. Ruth W Miller, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1300 116th Ave Ne, Bellevue, WA 98004 Phone: 425-454-7912 Fax: 425-454-7034 | |
Michael E Lee, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 11511 Ne 10th St, Bellevue, WA 98004 Phone: 425-502-3000 | |
Dr. Michael Rizen, M.D., PH.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1300 116th Ave Ne, Bellevue, WA 98004 Phone: 425-454-7912 Fax: 425-452-8720 | |
Charles D Birnbach, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1750 112th Ave Ne, Suite D050, Bellevue, WA 98004 Phone: 206-215-3850 Fax: 206-215-3870 | |
Dr. James Leonard Stroh, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1300 116th Ave Ne, Bellevue, WA 98004 Phone: 425-454-7912 Fax: 425-454-7034 | |
William Winston Waugh Sr., DO Ophthalmology Medicare: Medicare Enrolled Practice Location: 12301 Ne 10th Pl Ste 200, Bellevue, WA 98005 Phone: 425-450-2020 Fax: 425-688-0620 |